{"nctId":"NCT03058666","briefTitle":"Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients","startDateStruct":{"date":"2017-03-29","type":"ACTUAL"},"conditions":["Respiratory Distress Syndrome"],"count":477,"armGroups":[{"label":"Aerosolized Calfactant","type":"EXPERIMENTAL","interventionNames":["Drug: Aerosolized Calfactant","Device: Solarys"]},{"label":"Usual Care","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Aerosolized Calfactant","otherNames":["Infasurf","Calfactant"]},{"name":"Solarys","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nRDS Patients\n\n1. NICU patient, ≥1hour of age and \\<24 hours of age.\n2. Clinical diagnosis of RDS, with or without chest X-ray data.\n3. Inspired oxygen ≥21% to maintain adequate oxygen saturation.\n4. Not intubated\n5. Requiring:\n\n   1. nasal continuous positive airway pressure (nCPAP).\n\nExclusion Criteria:\n\n1. Congenital anomaly limiting care options or requiring early surgery.\n2. Cardiopulmonary decompensation.\n\n   1. hypotension with metabolic acidosis (base excess \\< -10 meq/l).\n   2. Oxygen saturations \\< 88% at start of aerosolization.\n   3. PaCO2 ≥ 60 mmHg at start of aerosolization.\n3. Grade 3 or Grade 4 intraventricular hemorrhage by cranial ultrasound, if known.\n4. Acute hypoxic encephalopathy with or without seizures.","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Hour","maximumAge":"24 Hours","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Intubation and Instillation of Liquid Surfactant","description":"Percent of at risk subjects receiving endotracheal intubation and instillation of surfactant within the first 72 hours.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"120","spread":null}]}]}]},{"type":"SECONDARY","title":"Respiratory Support Requirements","description":"Difference of Respiratory support at 28 days","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"124","spread":null}]}]}]},{"type":"SECONDARY","title":"Air Leak","description":"Percent of at risk subjects with air leak at any time","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":13,"n":241},"commonTop":["Hyperbilirubinemia","Apnea","Anemia","Dysphagia","Hypoglycemia"]}}}